Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy.
The experiences of support persons of people newly diagnosed with multiple sclerosis: an interpretative phenomenological study.
[Chronic inflammatory demyelinating polyradiculoneuropathy(CIDP): Treatment and prognosis].
[Symptoms and neurological findings in patients with multiple sclerosis].
Chemotactic signaling and beyond: link between interleukin-16 and axonal degeneration in multiple sclerosis.
A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study.
Identification of genetic determinants of the sexual dimorphism in CNS autoimmunity.
Misfiring in multiple sclerosis: Cerebellar Channelopathy, a Potential Novel Target?
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.
Acute Respiratory Failure due to Neuromyelitis Optica Treated Successfully with Plasmapheresis.
Albumin and multiple sclerosis.
[Do new oral therapies show advantages in the basal therapy of multiple sclerosis? Con.]
Perceived Exertion Is Lower When Using a Functional Electrical Stimulation Neuroprosthesis Compared With an Ankle-Foot Orthosis in Persons With Multiple Sclerosis: A Preliminary Study.
Conformational Changes and Association of Membrane-Interacting Peptides in Myelin Membrane Models: A Case of the C-Terminal Peptide of Proteolipid Protein and the Antimicrobial Peptide Melittin.
Regulator of G-protein Signaling (RGS)1 and RGS10 Proteins as Potential Drug Targets for Neuroinflammatory and Neurodegenerative Diseases.
Atarax: Can I Order
Alterations in hippocampal myelin and oligodendrocyte precursor cells during epileptogenesis.
Correction: The Extracellular Domain of Myelin Oligodendrocyte Glycoprotein Elicits Atypical Experimental Autoimmune Encephalomyelitis in Rat and Macaque Species.
Re: S Shahrbanian, M Auais, P Duquette, K Anderson, NE Mayo. Does pain in individuals with multiple sclerosis affect employment? A systematic review and meta-analysis. Pain Res Manag 2013;18(5):e94-e100.
Transverse myelitis and bilateral optic neuritis in a patient with systemic lupus erythematosus.
Admission sodium level and prognosis in adult Guillain-Barré syndrome.
Determinants of Psychosocial Difficulties Experienced by Persons with Brain Disorders: Towards a 'Horizontal Epidemiology' Approach.
Effects of Eight-week Resistance Training Program in Men With Multiple Sclerosis.
Infectious and noninfectious granulomatosis in patient with multiple sclerosis: diagnostic dilemmas and followup.
Demyelinating and thrombotic diseases of the central nervous system: common pathogenic and triggering factors.
Pages
« first
‹ previous
…
715
716
717
718
719
720
721
722
723
…
next ›
last »